Skip to content

Epidemiology and genetic diagnosis of monogenic diabetes in Tianjin

Epidemiology and genetic diagnosis of monogenic diabetes in Tianjin

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072271
Enrollment
Unknown
Registered
2023-06-08
Start date
2017-05-01
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Monogenic diabetes

Interventions

Sponsors

Tianjin Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Diabetes patients who developed before 25 years old; Or they were diagnosed with diabetes before the age of 35, and two or more immediate relatives were diagnosed with diabetes before the age of 45; ? Body mass index (BMI) at diagnosis<28kg/m2; ? Anti glutamic acid decarboxylase antibody (GAD Ab), anti islet cell antibody (ICA Ab), and anti insulin autoantibody (IAA Ab) were all negative;

Exclusion criteria

Exclusion criteria: ? Secondary diabetes patients with other endocrine diseases, such as hyperthyroidism or hypothyroidism, hyperparathyroidism or hypothyroidism, acromegaly, Cushing's syndrome, autoimmune multiple endocrine diseases, etc; ? Systemic use of corticosteroids, immunosuppressants, and other drugs within the past 6 months; ? Patients with malignant tumors.

Design outcomes

Primary

MeasureTime frame
Prevalence of monogenic diabetes;

Secondary

MeasureTime frame
liver function;blood fat;glycosylated hemoglobin;

Countries

China

Contacts

Public ContactMing Liu

Tianjin Medical University General Hospital

mingliu@tmu.edu.cn+86 183 2201 7516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026